163 related articles for article (PubMed ID: 26773278)
1. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
[TBL] [Abstract][Full Text] [Related]
2. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.
Stepien M; Duarte-Salles T; Fedirko V; Floegel A; Barupal DK; Rinaldi S; Achaintre D; Assi N; Tjønneland A; Overvad K; Bastide N; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Bamia C; Lagiou P; Saieva C; Agnoli C; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Dorronsoro M; Gavrila D; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Gunter M; Cross A; Vineis P; Romieu I; Scalbert A; Jenab M
Int J Cancer; 2016 Jan; 138(2):348-60. PubMed ID: 26238458
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
Aleksandrova K; Boeing H; Nöthlings U; Jenab M; Fedirko V; Kaaks R; Lukanova A; Trichopoulou A; Trichopoulos D; Boffetta P; Trepo E; Westhpal S; Duarte-Salles T; Stepien M; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Dossus L; Racine A; Lagiou P; Bamia C; Benetou V; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita B; Peeters PH; Gram IT; Lund E; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Gavrila D; Barricarte A; Dorronsoro M; Ohlsson B; Lindkvist B; Johansson A; Sund M; Khaw KT; Wareham N; Travis RC; Riboli E; Pischon T
Hepatology; 2014 Sep; 60(3):858-71. PubMed ID: 24443059
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.
Hughes DJ; Duarte-Salles T; Hybsier S; Trichopoulou A; Stepien M; Aleksandrova K; Overvad K; Tjønneland A; Olsen A; Affret A; Fagherazzi G; Boutron-Ruault MC; Katzke V; Kaaks R; Boeing H; Bamia C; Lagiou P; Peppa E; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Peeters PH; Engeset D; Weiderpass E; Lasheras C; Agudo A; Sánchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Hemmingsson O; Wareham NJ; Khaw KT; Bradbury KE; Cross AJ; Gunter M; Riboli E; Romieu I; Schomburg L; Jenab M
Am J Clin Nutr; 2016 Aug; 104(2):406-14. PubMed ID: 27357089
[TBL] [Abstract][Full Text] [Related]
5. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort.
Stepien M; Duarte-Salles T; Fedirko V; Trichopoulou A; Lagiou P; Bamia C; Overvad K; Tjønneland A; Hansen L; Boutron-Ruault MC; Fagherazzi G; Severi G; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Klinaki E; Palli D; Grioni S; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Skeie G; Weiderpass E; Parr CL; Quirós JR; Buckland G; Molina-Montes E; Amiano P; Chirlaque MD; Ardanaz E; Sonestedt E; Ericson U; Wennberg M; Nilsson LM; Khaw KT; Wareham N; Bradbury KE; Ward HA; Romieu I; Jenab M
Eur J Nutr; 2016 Feb; 55(1):7-20. PubMed ID: 25528243
[TBL] [Abstract][Full Text] [Related]
6. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans.
Stepien M; Hughes DJ; Hybsier S; Bamia C; Tjønneland A; Overvad K; Affret A; His M; Boutron-Ruault MC; Katzke V; Kühn T; Aleksandrova K; Trichopoulou A; Lagiou P; Orfanos P; Palli D; Sieri S; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Lasheras C; Bonet Bonet C; Molina-Portillo E; Dorronsoro M; Huerta JM; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Shungin D; Wareham N; Khaw KT; Travis RC; Freisling H; Cross AJ; Schomburg L; Jenab M
Br J Cancer; 2017 Feb; 116(5):688-696. PubMed ID: 28152549
[TBL] [Abstract][Full Text] [Related]
7. Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
Katzke V; Johnson T; Sookthai D; Hüsing A; Kühn T; Kaaks R
BMJ Open; 2020 Mar; 10(3):e033532. PubMed ID: 32152162
[TBL] [Abstract][Full Text] [Related]
8. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
9. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.
Aleksandrova K; Bamia C; Drogan D; Lagiou P; Trichopoulou A; Jenab M; Fedirko V; Romieu I; Bueno-de-Mesquita HB; Pischon T; Tsilidis K; Overvad K; Tjønneland A; Bouton-Ruault MC; Dossus L; Racine A; Kaaks R; Kühn T; Tsironis C; Papatesta EM; Saitakis G; Palli D; Panico S; Grioni S; Tumino R; Vineis P; Peeters PH; Weiderpass E; Lukic M; Braaten T; Quirós JR; Luján-Barroso L; Sánchez MJ; Chilarque MD; Ardanas E; Dorronsoro M; Nilsson LM; Sund M; Wallström P; Ohlsson B; Bradbury KE; Khaw KT; Wareham N; Stepien M; Duarte-Salles T; Assi N; Murphy N; Gunter MJ; Riboli E; Boeing H; Trichopoulos D
Am J Clin Nutr; 2015 Dec; 102(6):1498-508. PubMed ID: 26561631
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
[TBL] [Abstract][Full Text] [Related]
11. Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank.
He MM; Fang Z; Hang D; Wang F; Polychronidis G; Wang L; Lo CH; Wang K; Zhong R; Knudsen MD; Smith SG; Xu RH; Song M
Int J Cancer; 2021 Apr; 148(8):1867-1878. PubMed ID: 33091956
[TBL] [Abstract][Full Text] [Related]
12. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
[TBL] [Abstract][Full Text] [Related]
13. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Kunutsor SK; Apekey TA; Khan H
Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
[TBL] [Abstract][Full Text] [Related]
14. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
[TBL] [Abstract][Full Text] [Related]
15. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
16. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
Li J; Tao H; Zhang E; Huang Z
Cancer Med; 2021 Jul; 10(14):4844-4854. PubMed ID: 34145988
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of traditional hepatobiliary biomarkers of drug-induced liver injury in the rat.
Ennulat D; Magid-Slav M; Rehm S; Tatsuoka KS
Toxicol Sci; 2010 Aug; 116(2):397-412. PubMed ID: 20466777
[TBL] [Abstract][Full Text] [Related]
19. The associations between liver enzymes and the risk of metabolic syndrome in the elderly.
Liu CF; Zhou WN; Lu Z; Wang XT; Qiu ZH
Exp Gerontol; 2018 Jun; 106():132-136. PubMed ID: 29499373
[TBL] [Abstract][Full Text] [Related]
20. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
